Letrozole and ribociclib and Liver disease
Result of checking the interaction of drug Letrozole and ribociclib and disease Liver disease for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Letrozole is extensively metabolized by the liver. The pharmacokinetic disposition of letrozole has not been assessed in patients with severe hepatic impairment. No dosage modification is recommended for patients with mild to moderate hepatic impairment, however, therapy with letrozole should be administered cautiously to patients with severe hepatic impairment.
- "Product Information. Femara (letrozole)." Novartis Pharmaceuticals, East Hanover, NJ.
Generic Name: letrozole / ribociclib
Brand Name: Kisqali Femara Co-Pack 200 mg-25 mg Dose, Kisqali Femara Co-Pack 400 mg-25 mg Dose, Kisqali Femara Co-Pack 600 mg-25 mg Dose
Synonyms: n.a.
Letrozole and ribociclib - choroba wątroby 
Letrozole and ribociclib - doença hepática 
Letrozole and ribociclib - penyakit hati 
Letrozole and ribociclib - penyakit hati 
Letrozole and ribociclib - malattia del fegato 
Letrozole and ribociclib - maladie du foie 
Letrozole and ribociclib - Leber erkrankung 
Letrozole and ribociclib - enfermedad del higado 
Letrozole and ribociclib - заболевание печени 
Letrozole and ribociclib - karaciğer hastalığı 
Letrozole and ribociclib - مرض الكبد 
Letrozole and ribociclib - 肝病